0000899243-23-010680.txt : 20230405
0000899243-23-010680.hdr.sgml : 20230405
20230405143018
ACCESSION NUMBER: 0000899243-23-010680
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230324
FILED AS OF DATE: 20230405
DATE AS OF CHANGE: 20230405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gibbs Michael Terrence
CENTRAL INDEX KEY: 0001665000
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 23802139
MAIL ADDRESS:
STREET 1: 12 STONEY BROOK RD.
CITY: HOPKINTON
STATE: MA
ZIP: 01748
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0407
4/A
2023-03-24
2023-03-28
0
0001492674
T2 Biosystems, Inc.
TTOO
0001665000
Gibbs Michael Terrence
101 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
General Counsel
0
Common Stock
2023-03-24
4
M
0
334
A
6851
D
Restricted Stock Units
2023-03-24
4
M
0
334
0.00
D
Common Stock
334
0
D
The Form 4, as originally filed, incorrectly reported the amount of shares acquired as a result of the vesting of the Restricted Stock Units as 333.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
On March 24, 2020 the reporting person was granted 1,000 RSU's that vest in three equal annual installments commencing on March 24, 2021
/s/ John Sprague, Attorney-in-fact
2023-04-05